262 related articles for article (PubMed ID: 32655554)
1. Interleukins in Thyroid Cancer: From Basic Researches to Applications in Clinical Practice.
Xi C; Zhang GQ; Sun ZK; Song HJ; Shen CT; Chen XY; Sun JW; Qiu ZL; Luo QY
Front Immunol; 2020; 11():1124. PubMed ID: 32655554
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive cells in tumor immune escape and metastasis.
Liu Y; Cao X
J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
[TBL] [Abstract][Full Text] [Related]
3. Immune Escape Mechanism is Impaired in the Microenvironment of Thyroid Lymph Node Metastasis.
Cunha LL; Nonogaki S; Soares FA; Vassallo J; Ward LS
Endocr Pathol; 2017 Dec; 28(4):369-372. PubMed ID: 28730569
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms and applications of interleukins in cancer immunotherapy.
Anestakis D; Petanidis S; Kalyvas S; Nday CM; Tsave O; Kioseoglou E; Salifoglou A
Int J Mol Sci; 2015 Jan; 16(1):1691-710. PubMed ID: 25590298
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation.
Park A; Lee Y; Kim MS; Kang YJ; Park YJ; Jung H; Kim TD; Lee HG; Choi I; Yoon SR
Front Immunol; 2018; 9():1859. PubMed ID: 30140269
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and Therapeutic Implications of microRNAs in Non-Small Cell Lung Cancer.
Ahn YH; Ko YH
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233641
[TBL] [Abstract][Full Text] [Related]
7. Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.
Chockley PJ; Keshamouni VG
J Immunol; 2016 Aug; 197(3):691-8. PubMed ID: 27431984
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in understanding immune phenotypes of thyroid carcinomas: prognostication and emerging therapies.
Liotti F; Prevete N; Vecchio G; Melillo RM
F1000Res; 2019; 8():. PubMed ID: 30854191
[TBL] [Abstract][Full Text] [Related]
9. Interleukins and cancer immunotherapy.
Yoshimoto T; Morishima N; Okumura M; Chiba Y; Xu M; Mizuguchi J
Immunotherapy; 2009 Sep; 1(5):825-44. PubMed ID: 20636026
[TBL] [Abstract][Full Text] [Related]
10. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis.
Han LT; Hu JQ; Ma B; Wen D; Zhang TT; Lu ZW; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
Diagn Pathol; 2019 Jun; 14(1):52. PubMed ID: 31159823
[TBL] [Abstract][Full Text] [Related]
11. Tumor-related interleukins: old validated targets for new anti-cancer drug development.
Setrerrahmane S; Xu H
Mol Cancer; 2017 Sep; 16(1):153. PubMed ID: 28927416
[TBL] [Abstract][Full Text] [Related]
12. The Role of Exosomes in Pancreatic Cancer Microenvironment.
Friedman A; Hao W
Bull Math Biol; 2018 May; 80(5):1111-1133. PubMed ID: 28382422
[TBL] [Abstract][Full Text] [Related]
13. Immune responses in the thyroid cancer microenvironment: making immunotherapy a possible mission.
Mould RC; van Vloten JP; AuYeung AWK; Karimi K; Bridle BW
Endocr Relat Cancer; 2017 Dec; 24(12):T311-T329. PubMed ID: 28912377
[TBL] [Abstract][Full Text] [Related]
14. Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion.
Jiang Y; Zhan H
Cancer Lett; 2020 Jan; 468():72-81. PubMed ID: 31605776
[TBL] [Abstract][Full Text] [Related]
15. The roles and clinical applications of interleukins in endometrial carcinoma.
Zang Y; Li H; Liu S; Zhao R; Zhang K; Zang Y; Wang Y; Xue F
Front Oncol; 2022; 12():1001693. PubMed ID: 36531027
[TBL] [Abstract][Full Text] [Related]
16. Role of chemokine receptors in thyroid cancer and immunotherapy.
Coperchini F; Croce L; Marinò M; Chiovato L; Rotondi M
Endocr Relat Cancer; 2019 Aug; 26(8):R465-R478. PubMed ID: 31146261
[TBL] [Abstract][Full Text] [Related]
17. The fundamental role of mechanical properties in the progression of cancer disease and inflammation.
Mierke CT
Rep Prog Phys; 2014 Jul; 77(7):076602. PubMed ID: 25006689
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-22 promotes development of malignant lesions in a mouse model of spontaneous breast cancer.
Katara GK; Kulshrestha A; Schneiderman S; Riehl V; Ibrahim S; Beaman KD
Mol Oncol; 2020 Jan; 14(1):211-224. PubMed ID: 31725949
[TBL] [Abstract][Full Text] [Related]
19. Regulation of angiostatic chemokines driven by IL-12 and IL-27 in human tumors.
Airoldi I; Ribatti D
J Leukoc Biol; 2011 Nov; 90(5):875-82. PubMed ID: 21750124
[TBL] [Abstract][Full Text] [Related]
20. Thyroid cancer stem-like cells and epithelial-mesenchymal transition in thyroid cancers.
Hardin H; Montemayor-Garcia C; Lloyd RV
Hum Pathol; 2013 Sep; 44(9):1707-13. PubMed ID: 23528862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
